Metlife Inc [NYSE: MET] closed the trading session at $77.52.
The stocks have a year to date performance of 17.22 percent and weekly performance of 3.33 percent. The stock has been moved at 10.00 percent over the last six months. The stock has performed 14.07 percent around the most recent 30 days and changed 10.25 percent over the most recent 3-months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
If compared to the average trading volume of 3.20M shares, MET reached to a volume of 2951920 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Metlife Inc [MET]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MET shares is $86.23 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MET stock is a recommendation set at 1.68. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Goldman have made an estimate for Metlife Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 08, 2024. While these analysts kept the previous recommendation, Barclays raised their target price to Overweight. The new note on the price target was released on November 17, 2023, representing the official price target for Metlife Inc stock. Previously, the target price had yet another raise to $71, while Deutsche Bank analysts kept a Hold rating on MET stock. On September 14, 2023, analysts increased their price target for MET shares from 58 to 72.
The Average True Range (ATR) for Metlife Inc is set at 1.32, with the Price to Sales ratio for MET stock in the period of the last 12 months amounting to 0.79. The Price to Book ratio for the last quarter was 2.00. Price to Free Cash Flow for MET in the course of the last twelve months was 3.62.
MET stock trade performance evaluation
Metlife Inc [MET] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 3.33. With this latest performance, MET shares gained by 14.07% in over the last four-week period, additionally plugging by 10.00% over the last 6 months – not to mention a rise of 20.56% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MET stock in for the last two-week period is set at 69.70, with the RSI for the last a single of trading hit 77.52, and the three-weeks RSI is set at 64.86 for Metlife Inc [MET]. The present Moving Average for the last 50 days of trading for this stock 73.03, while it was recorded at 77.05 for the last single week of trading, and 70.26 for the last 200 days.
Metlife Inc [MET]: An insightful look at the core fundamentals
Metlife Inc’s liquidity data is similarly interesting compelling, with a Current Ratio set at 3.97.
Earnings per share (EPS) analysis for Metlife Inc [MET] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MET. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Metlife Inc go to 11.50%.
Metlife Inc [MET]: Institutional Ownership
There are presently around $76.12%, or 91.11%% of MET stock, in the hands of institutional investors. The top three institutional holders of MET stocks are: VANGUARD GROUP INC with ownership of 58.56 million shares, which is approximately 8.0975%. DODGE & COX, holding 56.35 million shares of the stock with an approximate value of $$3.96 billion in MET stocks shares; and DODGE & COX, currently with $$3.34 billion in MET stock with ownership which is approximately 6.5703%.
